June 7, 2024
Brian Bloom, Chairman and Chief Executive Officer of Bloom Burton & Co. comments in the Hamilton City Magazine on the positive impact of Fusion Pharmaceuticals on the growth of Hamilton’s life sciences ecosystem.
Fusion Pharmaceuticals started as a spinout company from McMaster University. On June 4, 2024, the company was acquired by British pharmaceutical company, AstraZeneca.